{"id":"W4389030754","doi":"10.1093/ofid/ofad500.1422","title":"1587. SOLAR 12-Month North American Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF","year":2023,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Emtricitabine; Tolerability; Tenofovir alafenamide; Clinical endpoint; Population; Regimen; Rilpivirine; Internal medicine; Randomized controlled trial; Adverse effect; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Family medicine; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006316261,0.0003879757,0.00158275,0.0003544405,0.0002438959,0.0001244414,0.0002673474,0.00006931147,0.000114058],"category_scores_gemma":[0.001135086,0.0002905673,0.0004760658,0.001016004,0.0003339008,0.0002271199,0.000310249,0.0001663774,0.0002600455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001533326,"about_ca_system_score_gemma":0.0005974211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002037027,"about_ca_topic_score_gemma":0.002652885,"domain_scores_codex":[0.9972425,0.000362779,0.0008242041,0.0004816863,0.0005153109,0.0005735493],"domain_scores_gemma":[0.9977973,0.000689917,0.0004243128,0.0005617792,0.0001476783,0.0003790483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6175753,0.00242004,0.2951751,0.00008339916,0.001728748,0.0002710302,0.000619934,0.00002956294,0.000009302626,0.0001798095,0.06460046,0.0173073],"study_design_scores_gemma":[0.9060618,0.001854905,0.05139562,0.0001632214,0.001595626,0.00002028998,0.0005401583,0.0001590275,0.0001994227,0.0003023141,0.03719094,0.0005166764],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9558365,0.00009307709,0.00003381787,0.004011466,0.0004585492,0.005635397,0.0004511008,0.0004232042,0.0330569],"genre_scores_gemma":[0.9840028,0.0004096524,0.0001019638,0.0002663375,0.0001021344,0.0007431901,0.001154105,0.00006595259,0.0131539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2884865,"threshold_uncertainty_score":0.9999546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01326574133440445,"score_gpt":0.2927594698144864,"score_spread":0.2794937284800819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}